person

Silvija C. V.

Country
Croatia
Department
NA

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
488
Sites with multiple studies

Has run more than one trial at 488 of 1052 partner sites.

Specializations

Liver Disease Management

The investigator specializes in treating complex hepatic conditions, with particular focus on non-alcoholic steatohepatitis (NASH) and acute-on-chronic liver failure (ACLF). Their research encompasses therapeutic interventions for patients with various stages of liver fibrosis and cirrhosis.

  • NASH with liver fibrosis
  • Advanced cirrhosis management
  • Acute-on-chronic liver failure

Their work includes evaluation of novel treatments for liver disease progression and mortality risk reduction in severe hepatic conditions.

Cardiovascular Prevention

The investigator focuses on atherosclerotic cardiovascular disease (ASCVD) prevention and treatment, with expertise in both primary and secondary prevention strategies for high-risk patients.

  • Primary ASCVD prevention
  • Secondary cardiovascular risk management
  • Major adverse cardiovascular events reduction

Their research addresses innovative approaches to preventing cardiovascular death, myocardial infarction, and ischemic stroke in various patient populations.

Metabolic Disorders

The investigator studies the intersection of metabolic conditions and organ dysfunction, particularly focusing on therapeutic interventions that address both hepatic and cardiovascular manifestations of metabolic disease.

  • Metabolic liver disease
  • Cardiometabolic risk factors
  • Novel therapeutic approaches

Their work explores innovative treatments targeting multiple aspects of metabolic disorders and their complications.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.